Ankara Numune Egitim ve Arastirma Hastanesi
Ankara, Turkey
Hospital in Ankara
Üniversiteler, Bilkent Ankara Şehir Hastanesi, Bilkent Blv. No 1, 06800 Çankaya
About Ankara Numune Egitim ve Arastirma Hastanesi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ankara Numune Egitim ve Arastirma Hastanesi
During the past decade, Ankara Numune Egitim ve Arastirma Hastanesi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
2020-05-14
2020-09-22
Completed
377
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab.
2020-07-30
2025-08-30
Active, not recruiting
179
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
2020-07-29
2024-11-30
Recruiting
498
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
2020-09-28
2025-06-27
Recruiting
750
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
2021-06-25
2025-06-30
Recruiting
210
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
Epidemiological Characteristics and Outcomes of Patients Admitted to Kenyan Critical Care Units (EPOK).
2021-01-01
2022-09-01
Recruiting
4,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara Numune Egitim ve Arastirma Hastanesi"
#1 collaborator was "AiCuris Anti-infective Cures AG" with 1 trials as a collaborator, "Tel Aviv University" with 1 trials as a collaborator, "UMC Utrecht" with 1 trials as a collaborator and "University of Bristol" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Ankara Numune Egitim ve Arastirma Hastanesi
According to Clinical.Site data, the most researched conditions in "Ankara Numune Egitim ve Arastirma Hastanesi" are
"Bacterial Resistance" (1 trials), "Crohn Disease" (1 trials), "Lean Body Mass" (1 trials), "Pulmonary Arterial Hypertension" (1 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Ankara Numune Egitim ve Arastirma Hastanesi" in a lesser frequency.
Clinical Trials Intervention Types at Ankara Numune Egitim ve Arastirma Hastanesi
Most popular intervention types in "Ankara Numune Egitim ve Arastirma Hastanesi" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amino Acid Supplement Group" (1 trials), "Daratumumab SC: daratumumab + rHuPH20" (1 trials), "Guselkumab Dose 1" (1 trials), "Guselkumab Dose 2" (1 trials) and "Guselkumab Dose 3" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ankara Numune Egitim ve Arastirma Hastanesi
The vast majority of trials in "Ankara Numune Egitim ve Arastirma Hastanesi" are
5 trials for "All" genders.
Clinical Trials Status at Ankara Numune Egitim ve Arastirma Hastanesi
Currently, there are NaN active trials in "Ankara Numune Egitim ve Arastirma Hastanesi".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ankara Numune Egitim ve Arastirma Hastanesi,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ankara Numune Egitim ve Arastirma Hastanesi, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".